Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

View source ↗

Summary

A Boston Scientific-sponsored registry evaluating real-world use of a drug-eluting device for peripheral vascular lesions; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Peripheral Vascular Diseases | Status: RECRUITING